We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More.
- Authors
Chen, Lihua; Dong, Binhua; Gao, Hangjing; Xue, Huifeng; Pan, Diling; Sun, Pengming
- Abstract
Purpose: Human papillomavirus-16 (HPV-16) is the most carcinogenic HPV genotype. This study aimed to evaluate the clinical value of POU5F1B and HPV-16-E2/E6 by cervical cytology specimens to predict the cervical intraepithelial neoplasia two grade and more (CIN2+). Methods: Finally, 248 patients with HPV-16 single infection were enrolled. Using cytology specimen by real-time quantitative PCR (qPCR), POU5F1B mRNA and HPV-16-E2/E6 were detected. The relationship of POU5F1B, HPV-16-E2/E6 and CIN2+ were analyzed, and the optimal cut-off values of POU5F1B and HPV-16-E2/E6 to predict CIN2+ were calculated. Results: The mean HPV-16-E2/E6 decreased significantly with cervical lesions development, especially compared with CIN2+ (p< 0.05). And the POU5F1B demonstrated higher expression in CIN2+ than that of normal cervical tissue and CIN1 (p< 0.05). What is more, POU5F1B was negatively correlated with HPV-16-E2/E6. It demonstrated that the area under the receiver operating characteristic curve (AUC) for POU5F1B (0.9058) was higher than that for HPV-16-E2/E6 (0.8983), and the sensitivity and specificity of POU5F1B in the diagnosis of CIN2+ were higher than HPV-E2/E6. Furthermore, it demonstrated that the POU5F1B had the highest odds ratio (OR= 16.84; 95% CI (8.00– 35.46)) for the detection of CIN 2+. Conclusion: HPV-16-E2/E6≤ 0.6471 or POU5F1B≥ 1.0310 in cervical exfoliated cells can be used as a reliable predictor of CIN2+. POU5F1B can be used as a new auxiliary biomarker to determine the HPV infection status and a reliable predictor of CIN2+. The expression of POU5F1B≥ 1.0310 had the highest OR for the detection of CIN2+.
- Subjects
CERVICAL intraepithelial neoplasia; RECEIVER operating characteristic curves; BIOMARKERS
- Publication
Journal of Inflammation Research, 2020, p813
- ISSN
1178-7031
- Publication type
Article
- DOI
10.2147/JIR.S278911